Last reviewed · How we verify
NCT05002491: HiProLep
Change in Leptin as a Predictor of Satiety With High Protein Feeding
NA trial testing High protein diet in Dietary Exposure in 19 participants. Completed in 31 December 2003.
31 December 2003
Quick facts
| Lead sponsor | Oregon Health and Science University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 19 |
| Start date | 1 May 2002 |
| Primary completion | 31 December 2003 |
| Estimated completion | 31 December 2003 |
Drugs / interventions tested
- High protein diet
Conditions studied
- Dietary Exposure — all drugs for Dietary Exposure →
Sponsor
Oregon Health and Science University
Who can join
Adults 18 to 65, any sex, with Dietary Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Body weight can be affected by the content of fat and carbohydrate in the diet. On average, people will lose a modest (\< 5 kg) amount of weight when switched from a high fat diet to a low fat, high carbohydrate diet. Determining mechanisms whereby changing the makeup of the diet can change one's body weight will be important in understanding why body weight in the US population is trending upward recently and what health care providers can recommend to reverse this trend. Previous studies have shown that increasing the carbohydrate and lowering the fat content in the diet leads to a change in the appearance of the hormone leptin in the blood over 24 hours. Leptin is an important signal from the fat cell to the brain that leads to a reduction in appetite and weight loss. A previous study found that after keeping people's weight stable, that the greater rise in leptin over the day on a low fat-high carbohydrate diet compared to a high fat diet predicted the reduction in calories they ate over a subsequent 12 weeks when their weight was allowed to freely fluctuate. Recent studies have also provided evidence that limiting fat and increasing the amount of protein in the diet also leads to modest weight loss. It is therefore proposed to test whether low fat, high protein diets also result a change in leptin secretion, and if this change predicts a reduction in appetite when they are allowed to eat freely.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Self-selected meal composition alters the relationship between same-day caloric intake and appetite scores in humans during a long-term ad-libitum feeding study.
Horgan AM, Palmbach GR, Jordan JM, Callahan HS, et al · · 2023 · cited 2× · PMID 36346472 · DOI 10.1007/s00394-022-03040-5
Verify or expand the search:
- PubMed search for NCT05002491
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High protein diet
Trials testing the same drug.
- NCT06749704 — Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD · NA · not yet recruiting
- NCT06141291 — Bed Rest Study SBI 2023 · NA · completed
- NCT02418039 — High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy · NA · terminated
Other recruiting trials for Dietary Exposure
Currently open trials in the same condition.
- NCT06526169 — Assessment of Human Exposure to Chemical Hazards · active not recruiting
- NCT06459661 — The Bowel Movement Monitoring (BoMoMo) Study · recruiting
- NCT06323538 — Cohort Study on Plant-based Diets (COPLANT Study) · recruiting
- NCT05763992 — Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach · Phase 2 · recruiting
- NCT06449170 — Discovery of Biomarkers of Intake of of Highly Consumed Foods in Mexico · NA · active not recruiting
Other Oregon Health and Science University trials
Trials by the same sponsor.
- NCT07431970 — Assessing Construction Execution Under Sleep Impairment · NA · not yet recruiting
- NCT07309757 — Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD) · not yet recruiting
- NCT07282639 — App-Based Certified Diabetes Education Therapy (AB-CDE) · NA · not yet recruiting
- NCT07322588 — Reentry Incentives and Support for Engagement With Contingency Management · NA · not yet recruiting
- NCT07220590 — Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05002491 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oregon Health and Science University
- Last refreshed: 30 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05002491.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing